BMS-986166 clinical trials
Also written BMS-986166.
- studies test it
- 7
- open now
- 0
- in phase 3
- 0
- first study started
- 2016
How each study uses BMS-986166 is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Development codes
- BMS-986166
- 7
Studies by the year they started
7 studies that test it; most in 2021 (4)
| Year | Studies |
|---|---|
| 2016 | 1 |
| 2017 | 1 |
| 2021 | 4 |
| 2022 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 7 · Other 0
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses BMS-986166 is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 7
- A Study of BMS-986166 or Branebrutinib for the Treatment of Participants With Atopic DermatitisCompletedPhase 2Bristol-Myers SquibbNCT05014438Written as BMS-986166
- A Study to Evaluate the Drug Levels of BMS-986166 in Healthy Male ParticipantsCompletedPhase 1Bristol-Myers SquibbNCT05409157Written as BMS-986166
- A Study to Assess the Effect of Itraconazole, Phenytoin and Gemfibrozil on the Drug Levels of BMS-986166 in Healthy ParticipantsCompletedPhase 1Bristol-Myers SquibbNCT04956627Written as BMS-986166
- A Study to Characterize the Drug Levels of an Oral Contraceptive With and Without BMS-986166 in Healthy Female Participants of Childbearing PotentialCompletedPhase 1Bristol-Myers SquibbNCT04934696Written as BMS-986166
- A Study to Evaluate the Safety, Tolerability, Drug Levels, and Drug Effects of BMS-986166 in Healthy Japanese ParticipantsCompletedPhase 1Bristol-Myers SquibbNCT04965402Written as BMS-986166
- A Multiple Dose Study to Assess the Safety and Tolerability of BMS-986166 in Healthy VolunteersCompletedPhase 1Bristol-Myers SquibbNCT03038711Written as BMS-986166
- A Randomized, Double Blind Placebo-Controlled, Single Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of BMS-986166 in Healthy SubjectsCompletedPhase 1Bristol-Myers SquibbNCT02790125Written as BMS-986166